Both Fostair 200/6 and Fostair NEXThaler 200/6 are licensed for the treatment of asthma where use of a combination product comprising a long-acting ß2-agonist and an inhaled corticosteroid is appropriate. Two inhalations are given twice daily.Dec 2, 2015